Study guide
13.1 Valvular Endocarditis, Vegetations, Abscess, and Complications
CCI Registered Cardiac Sonographer RCS
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: RCS Orientation and Clinical Context
1.1 RCS Identity, Exam Format, Application, and Retesting 1.2 Clinical History, Symptoms, Indications, and Risk Factors 1.3 Prior Studies, Serial Change, and Cross-Modality Context
2 Chapter 2: Orders, Safety, and Patient Preparation
2.1 Order Verification, Scope, and Protocol Selection 2.2 Sonographer Ergonomics and Staff Safety 2.3 Patient Preparation, Positioning, Consent, Infection Control, and Aftercare
3 Chapter 3: Reporting and 2-D TTE Foundations
3.1 Structured Findings, Significant Results, and Escalation 3.2 Standard 2-D TTE Windows, Views, and Acquisition Sequence 3.3 2-D Measurements, Foreshortening, Image Quality, and QA
4 Chapter 4: M-Mode and Doppler Acquisition
4.1 M-Mode Alignment, Timing, Measurements, and Pitfalls 4.2 Color Doppler Acquisition, Scale, Gain, and Jet Display 4.3 PW and CW Spectral Doppler Acquisition
5 Chapter 5: Advanced Doppler and Contrast
5.1 Tissue Doppler and Hemodynamic Sample Placement 5.2 Ultrasound-Enhancing Agents and LV Opacification 5.3 Agitated-Saline Studies and Intracardiac Shunts
6 Chapter 6: Stress Echocardiography
6.1 Exercise Stress Echo Protocols and Peak Imaging 6.2 Pharmacologic Stress Echo, Dobutamine, and Safety 6.3 Non-Ischemic Stress Echo and Hemodynamic Provocation
7 Chapter 7: TEE, Strain, and 3-D TEE
7.1 Assisting TEE: Preparation, Probe Safety, Views, and Complications 7.2 Strain Acquisition, Tracking Quality, and Reproducibility 7.3 3-D TEE Acquisition, Cropping, Orientation, and Artifacts
8 Chapter 8: 3-D TTE and the Aortic Valve
8.1 3-D TTE Full-Volume Acquisition and Quantitation 8.2 Aortic-Valve Anatomy, Morphology, and Function 8.3 Aortic Stenosis: Velocities, Gradients, Valve Area, and Flow States
9 Chapter 9: Aortic Regurgitation and Mitral Structure
9.1 Aortic Regurgitation Mechanisms and Integrated Severity 9.2 Mitral-Valve Anatomy, Motion, and Mechanisms 9.3 Mitral Stenosis: Planimetry, Gradients, Pressure Half-Time, and Suitability
10 Chapter 10: Mitral and Tricuspid Valve Findings
10.1 Mitral Regurgitation Mechanism, Quantitation, and Severity Integration 10.2 Tricuspid-Valve Anatomy, Structure, and Function 10.3 Tricuspid Stenosis Assessment
11 Chapter 11: Right-Sided Valve Disease
11.1 Tricuspid Regurgitation Mechanism and Severity 11.2 Pulmonic-Valve Anatomy, Structure, and Function 11.3 Pulmonic Stenosis Assessment
12 Chapter 12: Pulmonic Regurgitation and Prosthetic Valves
12.1 Pulmonic Regurgitation Mechanism and Severity 12.2 Normal Mechanical and Bioprosthetic Valve Assessment 12.3 Prosthetic Obstruction, Regurgitation, Thrombosis, and Patient–Prosthesis Mismatch
13 Chapter 13: Endocarditis and Cardiac Chambers
13.1 Valvular Endocarditis, Vegetations, Abscess, and Complications 13.2 LV and LA Size, Geometry, Volumes, Mass, and Function 13.3 RV and RA Size, Pressure, Volume, and Function
14 Chapter 14: Cardiomyopathy Phenotypes and Diastology
14.1 Dilated and Hypertrophic Cardiomyopathies, SAM, and LVOT Obstruction 14.2 Restrictive, Arrhythmogenic, and Stress Cardiomyopathies 14.3 Diastolic Function, Filling Pressure, Grading, and Pitfalls
15 Chapter 15: Systolic Function and Ischemia
15.1 LV Systolic Function, Simpson EF, Regional Motion, and Output 15.2 RV Systolic Function: TAPSE, S-prime, FAC, and Coupling 15.3 Ischemic Heart Disease, Coronary Territories, Stress Response, and Complications
16 Chapter 16: Pericardium and Great Vessels
16.1 Pericardial Effusion, Tamponade, Constriction, and Doppler Physiology 16.2 Great Vessels, Venous Return, and Pulmonary Artery Assessment 16.3 Aortic Root, Aneurysm, Dissection, and Coarctation
17 Chapter 17: Pulmonary Pressure, Masses, and Congenital Recognition
17.1 Pulmonary Hypertension, RAP/PASP Estimation, and RV Consequences 17.2 Cardiac Masses, Thrombus, Tumor, Vegetation, and Mimics 17.3 Adult Recognition of ASD, VSD, PFO, PDA, and Congenital Clues
18 Chapter 18: Devices, Strain, and Hemodynamics
18.1 ICDs, Pacemakers, Occluders, Closure Devices, and Mechanical Support 18.2 Strain Interpretation, Global Longitudinal Strain, and Disease Patterns 18.3 Cardiac Hemodynamics, Bernoulli, Continuity, Stroke Volume, and Shunts
19 Chapter 19: Infiltrative Disease and Physics Foundations
19.1 Amyloid, Sarcoid, and Other Infiltrative Disease Patterns 19.2 Ultrasound Wave Properties, Propagation, Frequency, and Wavelength 19.3 Artifact Recognition: Reverberation, Shadowing, Mirror, Refraction, and Aliasing
20 Chapter 20: Resolution and Doppler Optimization
20.1 Axial/Lateral Resolution, Frame Rate, Depth, Focus, and Trade-Offs 20.2 Spectral Doppler Optimization, Nyquist, Filters, Gain, and Angle 20.3 Color Doppler Optimization, Scale, Priority, Variance, and Gain
21 Chapter 21: 2-D, 3-D, and Contrast Optimization
21.1 2-D Optimization: Frequency, Gain, TGC, Harmonics, Depth, and Focus 21.2 3-D Optimization: Volume Rate, Stitching, Cropping, and Display 21.3 Contrast Optimization: Mechanical Index, Destruction, Replenishment, and Artifacts
13.1 Valvular Endocarditis, Vegetations, Abscess, and Complications
Key Takeaways Explain This Topic AI
IE is diagnosed by integrating echocardiography with clinical probability, microbiology, and other imaging; no single negative study independently excludes it.
A suspected vegetation is characterized by attachment, location, mobility, maximal length, tissue destruction, and reproducibility while common anatomic and artifact mimics are tested.
TEE is appropriate after limited or negative TTE with high suspicion, for prosthetic or device infection, and to define periannular or other complications.
New severe regurgitation, abscess, fistula, prosthetic dehiscence, ventricular compromise, or a large mobile lesion requires prompt communication under laboratory policy.
Last updated: July 2026
Treat endocarditis as a clinical-imaging diagnosis
Infective endocarditis, or IE, cannot be confirmed or excluded by one echocardiogram. Echocardiographic lesions must be integrated with blood cultures, pretest probability, examination, and other imaging. Before scanning, review the affected organism when known, fever and bacteremia course, prior IE, congenital disease, prosthetic valves, intracardiac devices, vascular access, injection exposure, new murmur, heart failure, embolic symptoms, and relevant earlier studies. The sonographer documents findings and limitations; the interpreting and clinical teams apply diagnostic criteria.
TTE is the first-line examination. Acquire complete native and prosthetic valve anatomy in multiple planes rather than stopping after finding one mass. Use parasternal, apical, subcostal, and modified windows; zoom at high frame rate for leaflet motion while retaining wide-field clips that show location. Sweep through each coaptation line, sewing ring, aortic root, mitral-aortic continuity, periannular tissue, and any visible lead. Color Doppler assesses new or worsening regurgitation, paravalvular flow, perforation, and abnormal communications. PW and CW Doppler describe hemodynamic consequences, not infection itself. Compare with prior images because unchanged calcification, sutures, strands, or prosthetic artifacts may mimic new disease.
Describe the lesion rather than naming every mass a vegetation
Finding Echocardiographic pattern What to document or challenge
Vegetation Irregular oscillating or independently mobile mass attached to endocardium, commonly on the upstream side of a valve Valve and surface, attachment, mobility, maximal length in the plane showing greatest extent, associated destruction, and serial change
Abscess Thickened, nonhomogeneous perivalvular region that may be echolucent or echodense Circumferential extent and relation to annulus, aortic root, mitral-aortic continuity, prosthesis, and conduction tissue
Pseudoaneurysm Pulsatile perivalvular cavity communicating with the circulation Neck, systolic or diastolic expansion, and color flow entering or leaving the cavity
Fistula Abnormal communication between adjacent chambers or vessels Origin, destination, continuous or phasic turbulent flow, and hemodynamic consequence
Perforation or aneurysm Tissue defect or localized outpouching with abnormal motion Color crossing a leaflet defect, new eccentric regurgitation, and affected segment
Prosthetic dehiscence New rocking motion or separation of the sewing ring Extent, paravalvular regurgitation, instability, and comparison with baseline
Vegetation size is measured as maximal length, not color-jet area. Scan orthogonal planes and use the clearest frame without including chordae, reverberation, or adjacent calcium. Report whether mobility is independent of the valve and whether the lesion interferes with closure. Lambl excrescences, redundant chordae, fibroelastoma, thrombus, calcific nodules, sutures, prosthetic material, and side-lobe or reverberation artifacts may resemble infection. A true lesion should remain anatomically coherent through the cardiac cycle and be reproducible in appropriate views. Alter depth, frequency, focus, gain, and insonation angle; a structure that changes position with the beam rather than anatomy is suspect.
Three-dimensional imaging may clarify the attachment, shape, and relation of a mass to prosthetic or native structures, but lower temporal resolution and stitch or dropout artifacts can hide or invent edges. Multiplanar review should confirm the finding in source planes. Absence of a 3-D rendering never overrules a convincing, reproducible 2-D lesion, and a dramatic rendering should not bypass clinical correlation.
Escalate when TTE cannot answer the clinical question
A negative or technically limited TTE does not rule out IE. Small or early vegetations, prosthetic shadowing, device-related infection, obesity, lung interference, and prior valve damage reduce sensitivity. TEE is indicated when suspicion remains high after negative or inconclusive TTE, when a prosthetic valve or intracardiac device is involved, and usually after a positive TTE when local extension or complications must be defined. TEE more clearly evaluates the atrial side of the mitral valve, aortic root and periannular tissue, prosthetic sewing rings, and device leads, but even TEE has blind zones and artifacts.
If the initial study is normal or inconclusive and clinical suspicion remains high, repeat TTE or TEE is generally recommended in about 5–7 days, or sooner if a new murmur, embolus, heart failure, conduction change, or other complication develops. CT can clarify periannular anatomy; metabolic or leukocyte imaging may add evidence in selected prosthetic or device cases. The next test is chosen by the clinical team. The essential echo conclusion states what was visualized, what was not, and whether the examination answers the suspected location.
Search systematically for complications
Valve destruction can cause acute severe MR or AR, pulmonary edema, and low output before chambers enlarge. Periannular infection may form an abscess, pseudoaneurysm, or fistula; new atrioventricular block is an important clinical clue to extension near conduction tissue. Prosthetic infection can produce dehiscence and major paravalvular regurgitation. Left-sided vegetations can embolize to brain, spleen, kidney, or peripheral arteries, whereas right-sided or device-related disease can cause septic pulmonary emboli. Echo may show the cardiac source and consequences but does not exclude extracardiac complications.
Assess ventricular size and function, filling pressure clues, pulmonary pressure, regurgitant severity, pericardial effusion, and shunts or communications. Acute severe regurgitation may have a deceptively brief or lower-velocity signal because pressures equalize rapidly. A large mobile vegetation, new severe regurgitation, suspected abscess, fistula, prosthetic instability, or new ventricular dysfunction requires immediate communication through laboratory policy. Do not delay notification while perfecting optional measurements, and do not prescribe antibiotics or surgery from the scanning room. A defensible endocarditis study combines complete acquisition, explicit uncertainty, timely escalation, and urgent communication.
One negative study does not exclude IE
Escalate to TEE when suspicion remains high, TTE is nondiagnostic, or prosthetic material or a device limits assessment. If suspicion persists after normal or inconclusive imaging, repeat echocardiography in about 5–7 days—or sooner with a new complication—may reveal evolving disease.